相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Heart Disease and Stroke Statistics-2009 Update A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Donald Lloyd-Jones et al.
CIRCULATION (2009)
Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia
Valeria C. Sandrim et al.
HYPERTENSION (2008)
Molecular mechanisms of preeclampsia
Walter P. Mutter et al.
MICROVASCULAR RESEARCH (2008)
Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis
Shenhong Wu et al.
LANCET ONCOLOGY (2008)
Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions
Andrew Advani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mechanisms of adverse effects of anti-VEGF therapy for cancer
T. Kamba et al.
BRITISH JOURNAL OF CANCER (2007)
Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: Systematic review and meta-analysis
Xiaolei Zhu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
Steven D. Crowley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Bevacizumab in the treatment of metastatic colorectal cancer: Safety profile and management of adverse events
Herbert Hurwitz et al.
SEMINARS IN ONCOLOGY (2006)
Increased collagen content in insulin-resistant skeletal muscle
R Berria et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Prostacyclin protects against elevated blood pressure and cardiac fibrosis
H Francois et al.
CELL METABOLISM (2005)
Role for thromboxane receptors in angiotensin-II-Induced hypertension
H Francois et al.
HYPERTENSION (2004)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase
ZG Jin et al.
CIRCULATION RESEARCH (2003)
Vascular endothelial growth factor in ischemia for vascular angiogenesis
TD Henry et al.
CIRCULATION (2003)
Cardiovascular and renal control in NOS-deficient mouse models
PA Ortiz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase
I Fleming et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration
HS Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool
GM Butz et al.
PHYSIOLOGICAL GENOMICS (2001)
Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family
I Zachary et al.
CARDIOVASCULAR RESEARCH (2001)
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
SA Bustin
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2000)